메뉴 건너뛰기




Volumn 34, Issue 21, 2015, Pages 2711-2720

Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTAMIC ACID; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; [(3,4 DIHYDRO 2H PYRANO[2,3 B]QUINOLIN 7 YL) (CIS 4 METHOXYCYCLOHEXYL)METHANONE]; (3,4-DIHYDRO-2H-PYRANO(2,3)B-QUINOLIN-7-YL)-(CIS-4-METHOXYCYCLOHEXYL) METHANONE; METABOTROPIC GLUTAMATE RECEPTOR TYPE 1; QUINOLINES; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 84930273416     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.231     Document Type: Article
Times cited : (23)

References (53)
  • 1
    • 0003964363 scopus 로고    scopus 로고
    • American Cancer Society: Atlant, GA, USA
    • American Cancer Society. Cancer Facts & Figures 2013. American Cancer Society: Atlant, GA, USA, 2013.
    • (2013) Cancer Facts & Figures 2013
  • 3
    • 83455218210 scopus 로고    scopus 로고
    • Molecular targeted therapy in melanoma: A way to reverse resistance to conventional drugs
    • Maira F, Catania A, Candido S, Russo AE, McCubrey JA, Libra M et al. Molecular targeted therapy in melanoma: A way to reverse resistance to conventional drugs. Curr Drug Deliv 2012; 9: 17-29.
    • (2012) Curr Drug Deliv , vol.9 , pp. 17-29
    • Maira, F.1    Catania, A.2    Candido, S.3    Russo, A.E.4    McCubrey, J.A.5    Libra, M.6
  • 4
    • 33947213963 scopus 로고    scopus 로고
    • Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma
    • Namkoong J, Shin SS, Lee HJ, Marín YE, Wall BA, Goydos JS et al. Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res 2007; 67: 2298-2305.
    • (2007) Cancer Res , vol.67 , pp. 2298-2305
    • Namkoong, J.1    Shin, S.S.2    Lee, H.J.3    Marín, Y.E.4    Wall, B.A.5    Goydos, J.S.6
  • 5
    • 0037994016 scopus 로고    scopus 로고
    • Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia
    • Pollock PM, Cohen-Solal K, Sood R, Namkoong J, Martino JJ, Koganti A et al. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet 2003; 34: 108-112.
    • (2003) Nat Genet , vol.34 , pp. 108-112
    • Pollock, P.M.1    Cohen-Solal, K.2    Sood, R.3    Namkoong, J.4    Martino, J.J.5    Koganti, A.6
  • 6
  • 7
    • 79953316415 scopus 로고    scopus 로고
    • Riluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivo
    • Khan AJ, Wall B, Ahlawat S, Green C, Schiff D, Mehnert JM et al. Riluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivo. Clin Cancer Res 2011; 17: 1807-1814.
    • (2011) Clin Cancer Res , vol.17 , pp. 1807-1814
    • Khan, A.J.1    Wall, B.2    Ahlawat, S.3    Green, C.4    Schiff, D.5    Mehnert, J.M.6
  • 8
    • 49949117480 scopus 로고    scopus 로고
    • Metabotropic glutamate receptors (mGluRs) and cellular transformation
    • Shin SS, Martino JJ, Chen S. Metabotropic glutamate receptors (mGluRs) and cellular transformation. Neuropharmacology 2008; 55: 396-402.
    • (2008) Neuropharmacology , vol.55 , pp. 396-402
    • Shin, S.S.1    Martino, J.J.2    Chen, S.3
  • 9
    • 84869207308 scopus 로고    scopus 로고
    • Functional effects of GRM1 suppression in human melanoma cells
    • Wangari-Talbot J, Wall BA, Goydos JS, Chen S. Functional effects of GRM1 suppression in human melanoma cells. Mol Cancer Res 2012; 10: 1440-1450.
    • (2012) Mol Cancer Res , vol.10 , pp. 1440-1450
    • Wangari-Talbot, J.1    Wall, B.A.2    Goydos, J.S.3    Chen, S.4
  • 10
    • 57349145304 scopus 로고    scopus 로고
    • Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma
    • Ohtani Y, Harada T, Funasaka Y, Nakao K, Takahara C, Abdel-Daim M et al. Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma. Oncogene 2008; 27: 7162-7170.
    • (2008) Oncogene , vol.27 , pp. 7162-7170
    • Ohtani, Y.1    Harada, T.2    Funasaka, Y.3    Nakao, K.4    Takahara, C.5    Abdel-Daim, M.6
  • 11
    • 77955715672 scopus 로고    scopus 로고
    • The glutamate release inhibitor riluzole decreases migration, invasion, and proliferation of melanoma cells
    • Le MN, Chan JL, Rosenberg SA, Nabatian AS, Merrigan KT, Cohen-Solal KA et al. The glutamate release inhibitor riluzole decreases migration, invasion, and proliferation of melanoma cells. J Invest Dermatol 2010; 130: 2240-2249.
    • (2010) J Invest Dermatol , vol.130 , pp. 2240-2249
    • Le, M.N.1    Chan, J.L.2    Rosenberg, S.A.3    Nabatian, A.S.4    Merrigan, K.T.5    Cohen-Solal, K.A.6
  • 12
    • 0030995878 scopus 로고    scopus 로고
    • Pharmacology and functions of metabotropic glutamate receptors
    • Conn PJ, Pin JP. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997; 37: 205-237.
    • (1997) Annu Rev Pharmacol Toxicol , vol.37 , pp. 205-237
    • Conn, P.J.1    Pin, J.P.2
  • 13
    • 0028912822 scopus 로고
    • The metabotropic glutamate receptors: Structure and functions
    • Pin JP, Duvoisin R. The metabotropic glutamate receptors: Structure and functions. Neuropharmacology 1995; 34: 1-26.
    • (1995) Neuropharmacology , vol.34 , pp. 1-26
    • Pin, J.P.1    Duvoisin, R.2
  • 14
  • 15
  • 16
    • 84896762683 scopus 로고    scopus 로고
    • Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer
    • Banda M, Speyer CL, Semma SN, Osuala KO, Kounalakis N, Torres KE et al. Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer. PLoS ONE 2014; 9: 1-12.
    • (2014) PLoS ONE , vol.9 , pp. 1-12
    • Banda, M.1    Speyer, C.L.2    Semma, S.N.3    Osuala, K.O.4    Kounalakis, N.5    Torres, K.E.6
  • 17
    • 18244393785 scopus 로고    scopus 로고
    • Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance
    • Chang HJ, Yoo BC, Lim SB, Jeong SY, Kim WH, Park JG. Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance. Clin Cancer Res 2005; 11: 3288-3295.
    • (2005) Clin Cancer Res , vol.11 , pp. 3288-3295
    • Chang, H.J.1    Yoo, B.C.2    Lim, S.B.3    Jeong, S.Y.4    Kim, W.H.5    Park, J.G.6
  • 19
    • 39049193970 scopus 로고    scopus 로고
    • Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma
    • Park SY, Lee SA, Han IH, Yoo BC, Lee SH, Park JY et al. Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma. Oncol Rep 2007; 17: 81-87.
    • (2007) Oncol Rep , vol.17 , pp. 81-87
    • Park, S.Y.1    Lee, S.A.2    Han, I.H.3    Yoo, B.C.4    Lee, S.H.5    Park, J.Y.6
  • 20
    • 79957897718 scopus 로고    scopus 로고
    • Glutamate and the biology of gliomas
    • De Groot J, Sontheimer H. Glutamate and the biology of gliomas. Glia 2011; 59: 1181-1189.
    • (2011) Glia , vol.59 , pp. 1181-1189
    • De Groot, J.1    Sontheimer, H.2
  • 21
    • 0033198997 scopus 로고    scopus 로고
    • Glioma cells release excitotoxic concentrations of glutamate
    • Ye ZC, Sontheimer H. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 1999; 59: 4383-4391.
    • (1999) Cancer Res , vol.59 , pp. 4383-4391
    • Ye, Z.C.1    Sontheimer, H.2
  • 25
    • 84875632487 scopus 로고    scopus 로고
    • Two newly identified exons in human GRM1 express a novel splice variant of metabotropic glutamate 1 receptor
    • DiRaddo JO, Pshenichkin S, Gelb T, Wroblewski JT. Two newly identified exons in human GRM1 express a novel splice variant of metabotropic glutamate 1 receptor. Gene 2013; 519: 367-373.
    • (2013) Gene , vol.519 , pp. 367-373
    • Diraddo, J.O.1    Pshenichkin, S.2    Gelb, T.3    Wroblewski, J.T.4
  • 27
    • 0034057273 scopus 로고    scopus 로고
    • Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes
    • Frati C, Marchese C, Fisichella G, Copani A, Nasca MR, Storto M et al. Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes. J Cell Physiol 2000; 183: 364-372.
    • (2000) J Cell Physiol , vol.183 , pp. 364-372
    • Frati, C.1    Marchese, C.2    Fisichella, G.3    Copani, A.4    Nasca, M.R.5    Storto, M.6
  • 28
    • 84900005185 scopus 로고    scopus 로고
    • Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression
    • Wen Y, Li J, Koo J, Shin SS, Lin Y, Jeong BS et al. Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression. Cancer Res. 2014; 74: 2499-2509.
    • (2014) Cancer Res. , vol.74 , pp. 2499-2509
    • Wen, Y.1    Li, J.2    Koo, J.3    Shin, S.S.4    Lin, Y.5    Jeong, B.S.6
  • 29
    • 33745078628 scopus 로고    scopus 로고
    • Oligodendrocyte excitotoxicity determined by local glutamate accumulation and mitochondrial function
    • Deng W, Yue Q, Rosenberg PA, Volpe JJ, Jensen FE. Oligodendrocyte excitotoxicity determined by local glutamate accumulation and mitochondrial function. J Neurochem 2006; 98: 213-222.
    • (2006) J Neurochem , vol.98 , pp. 213-222
    • Deng, W.1    Yue, Q.2    Rosenberg, P.A.3    Volpe, J.J.4    Jensen, F.E.5
  • 31
    • 80655129636 scopus 로고    scopus 로고
    • VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells
    • Ringer L, Sirajuddin P, Heckler M, Ghosh A, Suprynowicz F, Yenugonda VM et al. VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells. Cancer Biol Ther 2011; 12: 818-826.
    • (2011) Cancer Biol Ther , vol.12 , pp. 818-826
    • Ringer, L.1    Sirajuddin, P.2    Heckler, M.3    Ghosh, A.4    Suprynowicz, F.5    Yenugonda, V.M.6
  • 33
    • 84865069757 scopus 로고    scopus 로고
    • Molecular pathways: Dysregulated glutamatergic signaling pathways in cancer
    • Prickett TD, Samuels Y. Molecular pathways: Dysregulated glutamatergic signaling pathways in cancer. Clin Cancer Res 2012; 18: 4240-4246.
    • (2012) Clin Cancer Res , vol.18 , pp. 4240-4246
    • Prickett, T.D.1    Samuels, Y.2
  • 34
    • 84884572685 scopus 로고    scopus 로고
    • Glutamate, glutamate receptors, and downstream signaling pathways
    • Willard SS, Koochekpour S. Glutamate, glutamate receptors, and downstream signaling pathways. Int J Biol Sci 2013; 9: 948-959.
    • (2013) Int J Biol Sci , vol.9 , pp. 948-959
    • Willard, S.S.1    Koochekpour, S.2
  • 37
    • 84868560533 scopus 로고    scopus 로고
    • Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells
    • Koochekpour S, Majumdar S, Azabdaftari G, Attwood K, Scioneaux R, Subramani D et al. Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells. Clin Cancer Res 2012; 18: 5888-5901.
    • (2012) Clin Cancer Res , vol.18 , pp. 5888-5901
    • Koochekpour, S.1    Majumdar, S.2    Azabdaftari, G.3    Attwood, K.4    Scioneaux, R.5    Subramani, D.6
  • 38
    • 85027946522 scopus 로고    scopus 로고
    • Exome sequencing identifies GRIN2A as frequently mutated in melanoma
    • Wei X, Walia V, Lin JC, Teer JK, Prickett TD, Gartner J et al. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet 2011; 43: 442-446.
    • (2011) Nat Genet , vol.43 , pp. 442-446
    • Wei, X.1    Walia, V.2    Lin, J.C.3    Teer, J.K.4    Prickett, T.D.5    Gartner, J.6
  • 42
    • 49949110710 scopus 로고    scopus 로고
    • Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor in conditions of trophic deprivation-possible role as a dependence receptor
    • Pshenichkin S, Doli?ska M, Klauzi?ska M, Luchenko V, Grajkowska E, Wroblewski JT. Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor in conditions of trophic deprivation-possible role as a dependence receptor. Neuropharmacology 2008; 55: 500-508.
    • (2008) Neuropharmacology , vol.55 , pp. 500-508
    • Pshenichkin, S.1    Doliska, M.2    Klauziska, M.3    Luchenko, V.4    Grajkowska, E.5    Wroblewski, J.T.6
  • 43
    • 77950517630 scopus 로고    scopus 로고
    • Dependence receptors: A new paradigm in cell signaling and cancer therapy
    • Goldschneider D, Mehlen P. Dependence receptors: A new paradigm in cell signaling and cancer therapy. Oncogene 2010; 29: 1865-1882.
    • (2010) Oncogene , vol.29 , pp. 1865-1882
    • Goldschneider, D.1    Mehlen, P.2
  • 48
    • 0141783841 scopus 로고    scopus 로고
    • Neuroprotection against NMDA excitotoxicity by group i metabotropic glutamate receptors is associated with reduction of NMDA stimulated currents
    • Blaabjerg M, Fang L, Zimmer J, Baskys A. Neuroprotection against NMDA excitotoxicity by group I metabotropic glutamate receptors is associated with reduction of NMDA stimulated currents. Exp Neurol 2003; 183: 573-580.
    • (2003) Exp Neurol , vol.183 , pp. 573-580
    • Blaabjerg, M.1    Fang, L.2    Zimmer, J.3    Baskys, A.4
  • 51
    • 77956211421 scopus 로고    scopus 로고
    • The protective signaling of metabotropic glutamate receptor 1 is mediated by sustained, beta-arrestin-1-dependent ERK phosphorylation
    • Emery AC, Pshenichkin S, Takoudjou GR, Grajkowska E, Wolfe BB, Wroblewski JT et al. The protective signaling of metabotropic glutamate receptor 1 is mediated by sustained, beta-arrestin-1-dependent ERK phosphorylation. J Biol Chem 2010; 285: 26041-26048.
    • (2010) J Biol Chem , vol.285 , pp. 26041-26048
    • Emery, A.C.1    Pshenichkin, S.2    Takoudjou, G.R.3    Grajkowska, E.4    Wolfe, B.B.5    Wroblewski, J.T.6
  • 52
    • 84900426582 scopus 로고    scopus 로고
    • Beneficial effects of RAF inhibitor in mutant BRAF splice variant-expressing melanoma
    • Edward HJ, Kevin Basile K, Aplin AE. Beneficial effects of RAF inhibitor in mutant BRAF splice variant-expressing melanoma. Mol Cancer Res 2014; 12: 795-802.
    • (2014) Mol Cancer Res , vol.12 , pp. 795-802
    • Edward, H.J.1    Kevin Basile, K.2    Aplin, A.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.